Literature DB >> 10940380

High affinity insulin binding by soluble insulin receptor extracellular domain fused to a leucine zipper.

P A Hoyne1, L J Cosgrove, N M McKern, J D Bentley, N Ivancic, T C Elleman, C W Ward.   

Abstract

Insulin receptors (IRs) that are truncated at the end of the ectodomain form dimers that bind insulin with different characteristics to wild type receptors. These soluble IRs have lowered affinity for insulin compared with full-length IR, and exhibit linear Scatchard plots in contrast to the curvilinear plots obtained with full-length IR, IR truncated at the C-terminus of the transmembrane region and IR ectodomains fused to the self-associating constant domains from Fc or lambda immunoglobulins. In this report, we have fused the IR ectodomain to the 33 residue leucine zipper from the transcriptional activator GCN4 of Saccharomyces cerevisiae. This fusion protein binds insulin with high affinity in a manner comparable to native receptor. The respective dissociation constants were Kd1 8.2 X 10(-11) M and Kd2 1.6 x 10(-8) M for hIRedZip and Kd1 5.7 x 10(-11) M and Kd2 6.3 x 10(-9) M for membrane-anchored, native receptor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940380     DOI: 10.1016/s0014-5793(00)01872-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

1.  Structural basis for negative cooperativity in growth factor binding to an EGF receptor.

Authors:  Diego Alvarado; Daryl E Klein; Mark A Lemmon
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

2.  Hormone-triggered conformational changes within the insulin-receptor ectodomain: requirement for transmembrane anchors.

Authors:  R R Flörke; K Schnaith; W Passlack; M Wichert; L Kuehn; M Fabry; M Federwisch; H Reinauer
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

3.  Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor.

Authors:  Nicholas J Bessman; Atrish Bagchi; Kathryn M Ferguson; Mark A Lemmon
Journal:  Cell Rep       Date:  2014-11-06       Impact factor: 9.423

4.  High-affinity insulin binding: insulin interacts with two receptor ligand binding sites.

Authors:  Linda Whittaker; Caili Hao; Wen Fu; Jonathan Whittaker
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

5.  Soluble mimics of a chemokine receptor: chemokine binding by receptor elements juxtaposed on a soluble scaffold.

Authors:  Amita Datta; Martin J Stone
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

Review 6.  Ligand-induced ErbB receptor dimerization.

Authors:  Mark A Lemmon
Journal:  Exp Cell Res       Date:  2008-10-31       Impact factor: 3.905

7.  Symmetric and asymmetric receptor conformation continuum induced by a new insulin.

Authors:  Xiaochun Xiong; Alan Blakely; Jin Hwan Kim; John G Menting; Ingmar B Schäfer; Heidi L Schubert; Rahul Agrawal; Theresia Gutmann; Carlie Delaine; Yi Wolf Zhang; Gizem Olay Artik; Allanah Merriman; Debbie Eckert; Michael C Lawrence; Ünal Coskun; Simon J Fisher; Briony E Forbes; Helena Safavi-Hemami; Christopher P Hill; Danny Hung-Chieh Chou
Journal:  Nat Chem Biol       Date:  2022-03-14       Impact factor: 16.174

Review 8.  Theoretical and computational studies of peptides and receptors of the insulin family.

Authors:  Harish Vashisth
Journal:  Membranes (Basel)       Date:  2015-02-11

9.  How IGF-1 activates its receptor.

Authors:  Jennifer M Kavran; Jacqueline M McCabe; Patrick O Byrne; Mary Katherine Connacher; Zhihong Wang; Alexander Ramek; Sarvenaz Sarabipour; Yibing Shan; David E Shaw; Kalina Hristova; Philip A Cole; Daniel J Leahy
Journal:  Elife       Date:  2014-09-25       Impact factor: 8.140

10.  How IGF-II Binds to the Human Type 1 Insulin-like Growth Factor Receptor.

Authors:  Yibin Xu; Nicholas S Kirk; Hariprasad Venugopal; Mai B Margetts; Tristan I Croll; Jarrod J Sandow; Andrew I Webb; Carlie A Delaine; Briony E Forbes; Michael C Lawrence
Journal:  Structure       Date:  2020-05-26       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.